Sorrento Therapeutics, Inc.
SRNE
SRNE was delisted on the 22nd of February, 2023.
84 hedge funds and large institutions have $114M invested in Sorrento Therapeutics, Inc. in 2015 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 30 increasing their positions, 22 reducing their positions, and 18 closing their positions.
107% more call options, than puts
Call options by funds: $870K | Put options by funds: $421K
36% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 22
5% less funds holding
Funds holding: 88 → 84 (-4)
8% less capital invested
Capital invested by funds: $124M → $114M (-$9.94M)
22% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 18
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WCM
Wildcat Capital Management
New York
|
+$7.7M |
| 2 |
Millennium Management
New York
|
+$2.72M |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
+$1.12M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$630K |
| 5 |
LCM
Landscape Capital Management
Englewood,
New Jersey
|
+$461K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACA
Avoro Capital Advisors
New York
|
-$8.48M |
| 2 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$4.74M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$3.19M |
| 4 |
AC
Aisling Capital
New York
|
-$2.95M |
| 5 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$2.52M |
SRNE Hedge Fund Activity: Q4 2015 in Review
84 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Sorrento Therapeutics, Inc. (SRNE) for Q4 2015, worth a combined $114M — down 8% from $124M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of SRNE and 14 opened new positions — a net loss of 4 holders — while 22 trimmed existing stakes and 30 added.
The largest buyer was Wildcat Capital Management, adding an estimated $7.7M. The largest seller was Avoro Capital Advisors, cutting an estimated $8.48M.
- 84 institutional investors held Sorrento Therapeutics, Inc. (SRNE) as of Q4 2015, down from 88 in Q3 2015.
- Funds reported $114M of Sorrento Therapeutics, Inc. stock for Q4 2015, down 8% quarter-over-quarter.
- 14 funds opened new Sorrento Therapeutics, Inc. positions in Q4 2015 and 18 closed out, a net change of -4 holders.
- The largest Sorrento Therapeutics, Inc. buyer in Q4 2015 was Wildcat Capital Management, an estimated $7.7M added.
- The largest Sorrento Therapeutics, Inc. seller in Q4 2015 was Avoro Capital Advisors, an estimated $8.48M sold.
Based on aggregated 13F filings for Q4 2015.